ENTITY
Biogen Inc

Biogen Inc (BIIB US)

153
Analysis
Health Care • United States
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
more
bearish•S&P 500 INDEX
•09 Jan 2019 03:12

U.S. Equity Strategy: Oversold Rally Continues

A combination of, optimism surrounding U.S.-China trade talks, and Fed Chairman Powell’s comments have led to a continuation of the oversold bounce...

Logo
718 Views
Share
•29 Oct 2018 13:52

Smartkarma’s Week That Was in JP/​​​​KR: Market Turbulence 10 Years After 2008, Coway, & Celltrion

The Korean and Japanese stock markets have fallen sharply in October. Nikkei is down 12% and KOSPI is down 14% in October. It has been 10 years...

Logo
499 Views
Share
•26 May 2018 07:11

The Week That Was In North Asia@Smartkarma: A Week of Cancellations & Baby Come Back

This past week was one of cancellations, highlighted by Trump cancelling his meeting with Kim Jong-Un and the Hyundai Motor Group cancelling the...

Logo
315 Views
Share
bullish•S&P 500 INDEX
•24 Jan 2018 06:51

U.S. Equity Strategy

Our long-term bullish outlook remains intact. The weight of the evidence still points to further upside, allowing, of course, for occasional...

Logo
561 Views
Share
•05 Jan 2018 09:35

Human Longevity

At KIS capital we try to keep ourselves at the forefront of technology and innovation, attempting to identify which industries may blossom, and...

Share
x